Clinical trials: Cardiac Toxicity

Malaria, Falciparum

Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam

• Completed
• Age: 2 to 65 years
• Phase 3
• Results posted

This study is a multi-centre, open-label randomised trial to assess the efficacy, safety and tolerability of the Triple ACT artemether-lumefantrine+amodiaquine (AL+AQ) compared to the ACT artemether-lumefantrine (AL) in…

Trial name

TACT-CV (NCT03355664)

Testing

ACT, TACT

Where

4 sites in Cambodia, Vietnam

Volunteers

310 people

Sponsor

University of Oxford